Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Recommendation of “Buy” from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the eight ratings firms that are covering the stock, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have issued a report on the […]
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the eight ratings firms that are covering the stock, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have issued a report on the […]
